[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100597335":3},{"organization":4,"outcomesModule":7,"designInfo":20,"detailedDescription":23,"studyPopulation":24,"armGroups":19,"interventions":25,"overallOfficials":19,"centralContacts":30,"locations":19,"responsibleParty":40,"collaborators":19,"id":44,"slug":19,"hasResults":45,"nctId":46,"briefTitle":47,"officialTitle":48,"acronym":19,"eligibilityCriteria":49,"healthyVolunteers":45,"sex":50,"minAge":51,"maxAge":52,"enrollmentInfo":53,"targetDuration":19,"studyType":56,"phases":19,"briefSummary":57,"conditions":58,"keywords":19,"overallStatus":60,"whyStopped":19,"lastUpdateSubmitDate":61,"lastUpdatePostDateStruct":62,"startDateStruct":65,"completionDateStruct":67,"leadSponsor":69,"locationsCount":19},{"fullName":5,"class":6},"Assiut University","OTHER",{"primaryOutcomes":8,"secondaryOutcomes":19,"otherOutcomes":19},[9,13,17],{"measure":10,"description":11,"timeFrame":12},"Glycated Hemoglobin level","Measurement of Hb level in all patients upon ICU admission.","Baseline",{"measure":14,"description":15,"timeFrame":16},"Red Cell Distribution Width (RDW)","Measurement of RDW in all patients upon ICU admission.","baseline",{"measure":18,"description":11,"timeFrame":16},"Hemoglobin (Hb) Level",null,{"allocation":19,"interventionModel":19,"interventionModelDescription":19,"primaryPurpose":19,"observationalModel":21,"timePerspective":22,"maskingInfo":19},"COHORT","PROSPECTIVE","Primary (Main): determine the levels of the GHI And RDW In Critically Ill Patients at Critical and intermediate care units.\n\nb. Secondary (Subsidiary): Evaluate the prognostic significance of these parameters on patient outcomes, such as overall survival, progression-free survival, response to treatment.","All patients except patients in exculcion critira",[26],{"type":27,"name":28,"description":29,"armGroupLabels":19,"otherNames":19},"DEVICE","Hbg and RDW","Hbg and RDW as prognstic indicator in critical ill patients",[31,36],{"name":32,"role":33,"phone":34,"phoneExt":19,"email":35},"Rania Moukhter Aziz eldeam","CONTACT","+201022004702","Moukhterrania@gmail.com",{"name":37,"role":33,"phone":38,"phoneExt":19,"email":39},"Alaa ELdean Abd Elmoniem, Prof","+201112732730","alaaelmoniem@aun.edu.eg",{"type":41,"investigatorFullName":42,"investigatorTitle":43,"investigatorAffiliation":5,"oldNameTitle":19,"oldOrganization":19},"PRINCIPAL_INVESTIGATOR","Rania Moukhter aziz aldean","Doctor","100597335",false,"NCT07057154","Glycated Hbg Index and RDW as Prognstic Indicator in Critical Ill Patients","Glycatetd Hemoglobin Index and Red Cell Distribution Width as Prognstic Indicator in Critical Ill Patients","Inclusion Criteria:\n\n1. patients admitted to Critical and Intermediate Care Units in Internal Medicine Department after history taking, examination and diagnosis\n2. diabtic Patients 3-animic Patients\n\nExclusion Criteria:\n\n* Patients under 18 years of age\n* ICU stay \\\u003C 24 h\n* patients without HbA1c, FBG, or RDW data or anything's that's affect the HbA1c .","ALL","18 Years","75 Years",{"count":54,"type":55},97,"ESTIMATED","OBSERVATIONAL","The aim of this study was to evaluate the impact of GHI and RDW as prognostic indicator in critically ill Patients.",[59],"Critical Ill Patients","NOT_YET_RECRUITING","2025-07-07",{"date":63,"type":64},"2025-07-09","ACTUAL",{"date":66,"type":55},"2025-07-05",{"date":68,"type":55},"2026-12-02",{"name":5,"class":6}]